References
- Henderson BE, Ross RK, Paganini-Hill A, et al. Estrogen use and cardiovascular disease. Am J Obstet Gynecol 1986: 154(6): 1181–6
- Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ (Clin Res) 1988: 297(6647): 519–22
- Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985: 102(3): 319–24
- Whitehead MI, Townsend PT, Pryse-Davies J, et al. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981: 305(27): 1599–605
- Gambrell RD Jr, Maier RC, Sanders BI, et al. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol 1983: 62(4): 435–43
- Abdalla HI, Hart DM, Lindsay R, et al. Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol 1985: 66(6): 789–92
- Hillner BE, Hollenberg JP, Pauker SG. Postmenopausal estrogens in prevention of osteoporosis: Benefit virtually without risk if cardiovascular effects are considered. Am J Med 1986: 80(6): 1115–27
- Bergkvist L, Adami H-O, Persson I, et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989: 321(5): 293–7
- American College of Obstetricians and Gynecologists. Statement by the American College of Obstetricians and Gynecologists on estrogen. estrogen-progestin, and breast cancer. Washington. DC: American College of Obstetricians and Gynecologists, 1989 Aug 3
- Barrett-Connor E. Postmenopausal estrogen replacement and breast cancer. (Editorial) N Engl J Med 1989: 321(5): 319–20
- Wells RG. A plan for giving hormone replacement therapy to postmenopausal women. Senior Patient 1989: 1(1): 68–70
- Nachtigall LE, Nachtigall RH, Nachtigall RD, et al. Estrogen replacement therapy II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979: 54(1): 74–9
- Gambrell RD Jr. The role of progestogens in estrogen replacement. Obstet Gynecol Forum 1988: 2(4): 5
- Hammond CB, Jelovsek FR, Lee KL, et al. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol 1979: 133(5): 525–36
- Notelovitz M. Exercise, nutrition, and the coagulation effects of estrogen replacement on cardiovascular health. Obstet Gynecol Clin North Am 1987: 14(1): 121–41
- Varma TR. Effect of estrogen replacement therapy on blood coagulation factors in postmenopausal women. Int J Gynaecol Obstet 1983: 21(4): 291–6
- Crane MG, Harris JJ, Winsor W 3d. Hypertension, oral contraceptive agents, and conjugated estrogens. Ann Intern Med 1971: 74(1): 13–21
- Hassager C, Riis BJ, Strom V, et al. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 1987: 76(4): 753–8
- Mashchak CA, Lobo RA. Estrogen replacement therapy and hypertension. J Reprod Med 1985: 30 (10 Suppl): 805–10